1. Home
  2. CADL vs TRVG Comparison

CADL vs TRVG Comparison

Compare CADL & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$11.07

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo trivago N.V.

TRVG

trivago N.V.

N/A

Current Price

$5.72

Market Cap

422.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
TRVG
Founded
1999
2005
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
422.6M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
CADL
TRVG
Price
$11.07
$5.72
Analyst Decision
Strong Buy
Hold
Analyst Count
7
6
Target Price
$19.00
$3.95
AVG Volume (30 Days)
1.2M
162.7K
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
$15.59
Revenue Next Year
N/A
$8.42
P/E Ratio
N/A
$16.98
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$2.59
52 Week High
$14.00
$6.49

Technical Indicators

Market Signals
Indicator
CADL
TRVG
Relative Strength Index (RSI) 38.37 54.19
Support Level $9.18 $2.76
Resistance Level $11.36 N/A
Average True Range (ATR) 0.74 0.42
MACD -0.39 -0.02
Stochastic Oscillator 19.78 34.55

Price Performance

Historical Comparison
CADL
TRVG

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.

Share on Social Networks: